Shelton Wealth Management LLC Sells 8,001 Shares of Corteva, Inc. $CTVA

Shelton Wealth Management LLC lessened its position in Corteva, Inc. (NYSE:CTVA) by 74.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,763 shares of the company’s stock after selling 8,001 shares during the period. Shelton Wealth Management LLC’s holdings in Corteva were worth $231,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Brighton Jones LLC boosted its stake in Corteva by 307.2% in the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock valued at $888,000 after purchasing an additional 11,760 shares during the period. Woodline Partners LP boosted its holdings in Corteva by 40.3% in the 1st quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock valued at $3,645,000 after purchasing an additional 16,644 shares during the period. EverSource Wealth Advisors LLC boosted its stake in shares of Corteva by 62.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock valued at $191,000 after buying an additional 980 shares during the period. Cresset Asset Management LLC raised its holdings in Corteva by 2.6% in the 2nd quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock valued at $526,000 after acquiring an additional 181 shares in the last quarter. Finally, Jump Financial LLC bought a new stake in shares of Corteva during the 2nd quarter valued at $1,464,000. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Trading Up 0.5%

Corteva stock traded up $0.46 during trading hours on Tuesday, reaching $86.85. 475,161 shares of the company’s stock were exchanged, compared to its average volume of 4,018,400. The firm’s 50 day simple moving average is $79.80 and its 200 day simple moving average is $76.94. Corteva, Inc. has a twelve month low of $60.53 and a twelve month high of $87.69. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The firm has a market capitalization of $58.09 billion, a PE ratio of 51.12, a PEG ratio of 2.62 and a beta of 0.56.

Corteva (NYSE:CTVA) last announced its earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating the consensus estimate of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The company had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. During the same quarter in the prior year, the company earned $1.13 EPS. The firm’s revenue for the quarter was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were given a dividend of $0.18 per share. The ex-dividend date of this dividend was Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.8%. Corteva’s dividend payout ratio (DPR) is 42.35%.

Analyst Upgrades and Downgrades

CTVA has been the topic of a number of analyst reports. CICC Research increased their price objective on shares of Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 13th. Oppenheimer upped their price target on shares of Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a report on Wednesday, April 22nd. Morgan Stanley increased their price target on shares of Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research report on Thursday, May 28th. Argus lifted their price objective on shares of Corteva from $80.00 to $91.00 and gave the company a “buy” rating in a research note on Tuesday, March 31st. Finally, UBS Group cut their target price on Corteva from $90.00 to $86.00 and set a “neutral” rating for the company in a research note on Tuesday, June 9th. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $88.90.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.